TA
TruWealth Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.5M | Buy |
142,557
+7,790
| +6% | +$1.45M | 1.46% | 20 |
|
|
2025
Q1 | $28.2M | Sell |
134,767
-22,874
| -15% | -$4.79M | 1.7% | 16 |
|
|
2024
Q4 | $28M | Buy |
157,641
+1,160
| +0.7% | +$206K | 1.69% | 18 |
|
|
2024
Q3 | $30.9M | Buy |
156,481
+2,171
| +1% | +$429K | 1.89% | 15 |
|
|
2024
Q2 | $26.5M | Buy |
154,310
+3,934
| +3% | +$675K | 1.76% | 18 |
|
|
2024
Q1 | $27.4M | Buy |
150,376
+932
| +0.6% | +$170K | 1.91% | 18 |
|
|
2023
Q4 | $23.2M | Buy |
149,444
+2,675
| +2% | +$415K | 1.77% | 19 |
|
|
2023
Q3 | $21.9M | Buy |
146,769
+4,221
| +3% | +$629K | 1.88% | 19 |
|
|
2023
Q2 | $19.2M | Buy |
142,548
+23,152
| +19% | +$3.12M | 1.65% | 20 |
|
|
2023
Q1 | $19M | Sell |
119,396
-21,177
| -15% | -$3.37M | 1.74% | 17 |
|
|
2022
Q4 | $22.7M | Buy |
140,573
+140
| +0.1% | +$22.6K | 2.22% | 13 |
|
|
2022
Q3 | $18.8M | Buy |
140,433
+4,124
| +3% | +$553K | 1.99% | 15 |
|
|
2022
Q2 | $20.9M | Buy |
136,309
+4,768
| +4% | +$730K | 2.24% | 10 |
|
|
2022
Q1 | $21.3M | Buy |
131,541
+1,089
| +0.8% | +$177K | 2.22% | 12 |
|
|
2021
Q4 | $17.7M | Buy |
130,452
+7,289
| +6% | +$987K | 1.79% | 15 |
|
|
2021
Q3 | $13.3M | Buy |
123,163
+5,225
| +4% | +$564K | 1.48% | 19 |
|
|
2021
Q2 | $13.3M | Buy |
117,938
+41,331
| +54% | +$4.66M | 1.56% | 17 |
|
|
2021
Q1 | $8.29M | Buy |
76,607
+5,169
| +7% | +$559K | 1.13% | 25 |
|
|
2020
Q4 | $7.66M | Buy |
+71,438
| New | +$7.66M | 1.14% | 26 |
|